$36.49
-0.96-2.56%
Last update: Oct 23, 7:59 PM
Roivant Sciences Ltd
ROIVNASDAQ
Roivant Sciences (ROIV) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.37 | $-0.36 | $-0.34 | $-0.32 |
| Actual | $-0.34 | $-0.27 | $-0.24 | $-0.28 |
| Surprise | +8.11% | +23.9% | +29.4% | +12.5% |
| Revenue | ||||
| Estimate | $2.3M | $3.7M | $6.1M | $6.7M |
| Actual | $1.4M | $2.5M | $2.0M | $1.6M |
| Surprise | -38.5% | -31.6% | -67.4% | -76.5% |
| Metric | Q2 '27E | Q3 '27E | Q4 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.46 | $-0.42 | $-0.55 |
| Revenue | |||
| Consensus | $3.5M | $11.9M | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | Aug 6, 2026 | $-0.34 | $-0.37 | 8.11 % |
| Q4 | May 20, 2026 | $-0.27 | $-0.36 | 23.9 % |
| Q3 | Feb 6, 2026 | $-0.24 | $-0.34 | 29.4 % |
| Q2 | Nov 10, 2025 | $-0.28 | $-0.32 | 12.5 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | Aug 6, 2026 | $1.44M | $2.35M | -38.5 % |
| Q4 | May 20, 2026 | $2.52M | $3.68M | -31.6 % |
| Q3 | Feb 6, 2026 | $2.00M | $6.13M | -67.4 % |
| Q2 | Nov 10, 2025 | $1.57M | $6.68M | -76.5 % |
